Scientific Program Committee News Today

A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the potential to spur advances in the treatment of many brain diseases. This research was presented at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, and the grouping of images highlighting targeted tracer uptake in spec...

Here's everything you need to know about about the 2024 APA Annual Meeting and how to prep for next year's meeting, from members of the Scientific Program Committee.

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Jeffrey A. Drebin, MD, PhD, has been named President-Elect of the American Surgical Assoc

- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program in patients with solid tumors and lymphoma -

This year’s Mid-Winter Conference of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well as the potential role of artificial intelligence (AI) in nuclear medicine during the Feb. 1-3, 2024 meeting in Orlando, FL.

The annual meeting will feature the latest in pulmonary, critical care, and sleep medicine, plus acrobatic fire dancers and a luau feast.

During its 2023 Annual Meeting, held June 24-27 in Chicago, the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI named Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford (CA), and clinical professor of radiology at the Stanford School of Medicine, as its President, introduced its new slate of officers and recognized 10 new fellows.

Omeros Corporation today announced that the slides presented yesterday in the “late-breaker” session at the 2023 European Hematology Association Congress in Frankfurt, Germany are now... | June 12, 2023

Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

– Late-breaking abstract detailing interim data from ongoing clinical trial of OMS906 in treatment-naïve PNH patients selected for June 11, 2023 oral presentation – ... | June 1, 2023